State the number of shares outstanding of each of the issuer's classes of common equity, as of June 30, 2004: 19,235,542 shares of common stock outstanding, $0.0001 par value per share.
ASSETS | | | | | | | |
| | | June 30, 2004 (Unaudited) | | | December 31, 2003 | |
| |
| |
| |
CURRENT ASSETS | | | | | | | |
Cash | | $ | 1,236,070 | | $ | 1,174,281 | |
Prepaid expenses | | | 153,686 | | | 318,871 | |
| |
| |
| |
Total Current Assets | | | 1,389,756 | | | 1,493,152 | |
| | | 854,735 | | | 24,277 | |
| | | 4,700,000 | | | 4,700,000 | |
DEPOSIT ON PURCHASE OF MACHINERY | | | 3,199,185 | | | 4,000,976 | |
OTHER ASSETS | | | 7,977 | | | 7,977 | |
| |
| |
| |
TOTAL ASSETS | | $ | 10,151,653 | | $ | 10,226,382 | |
| |
| |
| |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | |
CURRENT LIABILITIES | | | | | | | |
Accrued payroll taxes | | $ | -- | | $ | 15,616 | |
Accrued professional fees | | | 362,500 | | | 311,048 | |
Accrued expenses | | | 44,110 | | | 223,215 | |
| |
| |
| |
Total Current Liabilities | | | 406,610 | | | 549,879 | |
| |
| |
| |
COMMITMENTS AND CONTINGENCIES | | | | | | | |
| | | | | | | |
STOCKHOLDERS’ EQUITY | | | | | | | |
Preferred stock, $.0001 par value, 1,000,000 shares authorized, no shares issued | | | | | | | |
and outstanding | | | -- | | | -- | |
Common stock, $.0001 par value, 25,000,000 shares authorized, 19,235,542 and | | | | | | | |
18,715,103 shares issued and outstanding, respectively | | | 1,923 | | | 1,871 | |
Additional paid-in capital | | | 18,171,587 | | | 16,347,363 | |
Deferred consulting expense | | | (411,855 | ) | | (1,356,533 | ) |
Note receivable – related party | | | (235,000 | ) | | (235,000 | ) |
Interest receivable – related party | | | (4,918 | ) | | (3,074 | ) |
Deficit accumulated during development stage | | | (7,776,694 | ) | | (5,078,124 | ) |
| |
| |
| |
Total Stockholders' Equity | | | 9,745,043 | | | 9,676,503 | |
| |
| |
| |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | | $ | 10,151,653 | | $ | 10,226,382 | |
| |
| |
| |
See accompanying notes to the condensed consolidated financial statements.
DDS TECHNOLOGIES USA, INC.
(FORMERLY FISHTHEWORLD HOLDINGS, INC.)
AND SUBSIDIARY
(A DEVELOPMENT STAGE COMPANY)
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
| | | For the Three Months Ended June 30, 2004 | | | For the Three Months Ended June 30, 2003 | | | For the Six Months Ended June 30, 2004 | | | For the Six Months Ended June 30, 2003 | | | For the Period From July 17, 2002 (Inception) Through June 30, 2004 | |
| |
| |
| |
| |
| |
| |
REVENUES | | $ | - | | $ | - | | $ | - | | $ | - | | $ | - | |
| |
| |
| |
| |
| |
| |
EXPENSES | | | | | | | | | | | | | | | | |
Professional fees | | | 969,856 | | | 1,074,838 | | | 1,955,836 | | | 1,241,534 | | | 5,954,316 | |
General and administrative | | | 209,862 | | | 77,059 | | | 434,260 | | | 155,077 | | | 1,083,738 | |
Salaries and related taxes | | | 141,928 | | | 44,593 | | | 310,919 | | | 70,432 | | | 544,159 | |
Merger costs | | | | | | 100,000 | | | | | | 200,000 | | | 200,000 | |
| |
| |
| |
| |
| |
| |
Total Expenses | | | 1,321,646 | | | 1,296,490 | | | 2,701,015 | | | 1,667,043 | | | 7,782,213 | |
| | | | | | | | | | | | | | | | |
INTEREST INCOME | | | 1,523 | | | 1,230 | | | 2,445 | | | 1,230 | | | 5,519 | |
| |
| |
| |
| |
| |
| |
NET LOSS | | $ | (1,320,123 | ) | $ | (1,295,260 | ) | $ | (2,698,570 | ) | $ | (1,665,813 | ) | $ | (7,776,694 | ) |
| |
| |
| |
| |
| |
| |
NET LOSS PER SHARE – BASIC AND DILUTED | | $ | (0.07 | ) | $ | (0.08 | ) | $ | (0.14 | ) | $ | (0.10 | ) | | | |
| |
| |
| |
| |
| | | | |
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING – BASIC AND DILUTED | | | 18,920,153 | | | 16,240,145 | | | 18,822,255 | | | 15,981,526 | | | | |
| |
| |
| |
| |
| | | | |
See accompanying notes to the condensed consolidated financial statements.
DDS TECHNOLOGIES USA, INC.
(FORMERLY FISHTHEWORLD HOLDINGS, INC.)
AND SUBSIDIARY
(A DEVELOPMENT STAGE COMPANY)
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
FOR THE PERIOD FROM JULY 17, 2002 (INCEPTION) THROUGH JUNE 30, 2004
(UNAUDITED)
| | | Common Stock | | | Additional Paid-In Capital | | | | | | Deferred Consulting Expense | | | Note Receivable Related Party | | | Interest Receivable Related Party | | | | | | Total | |
| | | Shares | | | Amount | | | | | | | | | | | | | | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
Common stock issued for cash at inception | | | 10,767,255 | | $ | 1,077 | | $ | 957,328 | | $ | - | | $ | - | | | - | | | - | | | - | | $ | 958,405 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock issued for license valued at $1.00 per share | | | 3,500,000 | | | 350 | | | 3,499,650 | | | - | | | - | | | - | | | - | | | - | | | 3,500,000 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock issued for cash in December 2002 at $1.00 per share | | | 100,000 | | | 10 | | | 99,990 | | | - | | | - | | | - | | | - | | | - | | | 100,000 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock issued for cash in January 2003 at $1.00 per share | | | 200,000 | | | 20 | | | 199,980 | | | - | | | - | | | - | | | - | | | - | | | 200,000 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock issued for license in January 2003 at $1.00 per share | | | 500,000 | | | 50 | | | 499,950 | | | - | | | - | | | - | | | - | | | - | | | 500,000 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Note receivable – related party in February 2003 | | | - | | | - | | | - | | | - | | | - | | | (235,000 | ) | | - | | | - | | | (235,000 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest receivable – related party | | | - | | | - | | | - | | | - | | | - | | | - | | | (3,074 | ) | | - | | | (3,074 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock issued for cash in February, March and April 2003 at $1.00 per share | | | 800,000 | | | 80 | | | 799,920 | | | - | | | - | | | - | | | - | | | - | | | 800,000 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Recapitalization for merger in April 2003 | | | 429,000 | | | 43 | | | (43 | ) | | - | | | - | | | - | | | - | | | - | | | - | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock issued for cash in May 2003 at $1.00 per share | | | 100,000 | | | 10 | | | 99,990 | | | - | | | - | | | - | | | - | | | - | | | 100,000 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock subscribed at $1.00 per share | | | 1,500,000 | | | 150 | | | 1,499,850 | | | (1,500,000 | ) | | - | | | - | | | - | | | - | | | - | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collection of subscription receivable in July 2003 | | | - | | | - | | | - | | | 500,000 | | | - | | | - | | | - | | | - | | | 500,000 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Warrants issued for consulting expense in April 2003 | | | - | | | - | | | 1,274,848 | | | - | | | (1,274,848 | ) | | - | | | - | | | - | | | - | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock issued for cash in July and August 2003 at $3.50 per share, net | | | 502,714 | | | 50 | | | 1,020,444 | | | - | | | - | | | - | | | - | | | - | | | 1,020,494 | |
See accompanying notes to the condensed consolidated financial statements.
DDS TECHNOLOGIES USA, INC.
(FORMERLY FISHTHEWORLD HOLDINGS, INC.)
AND SUBSIDIARY
(A DEVELOPMENT STAGE COMPANY)
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
FOR THE PERIOD FROM JULY 17, 2002 (INCEPTION) THROUGH JUNE 30, 2004
(UNAUDITED)
| | | Common Stock | | | Additional Paid-In Capital | | | | | | Deferred Consulting Expense | | | Note Receivable Related Party | | | Interest Receivable Related Party | | | | | | Total | |
| | | Shares | | | Amount | | | | | | | | | | | | | | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
Warrants issued with the sale of common stock in July and August 2003 | | | - | | | - | | | 563,056 | | | - | | | - | | | - | | | - | | | - | | | 563,056 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock issued for services in August and September 2003 | | | 175,000 | | | 17 | | | 1,298,233 | | | - | | | (1,298,250 | ) | | - | | | - | | | - | | | - | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock issued for settlement | | | 60,000 | | | 6 | | | 464,994 | | | - | | | - | | | - | | | - | | | - | | | 465,000 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cancellation of subscription receivable | | | (1,000,000 | ) | | (100 | ) | | (999,900 | ) | | 1,000,000 | | | - | | | - | | | - | | | - | | | - | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock issued for cash in October 2003 at $6.00 per share, net | | | 904,334 | | | 90 | | | 2,896,206 | | | - | | | - | | | - | | | - | | | - | | | 2,896,296 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Warrants issued with the sale of common stock in October 2003 | | | - | | | - | | | 1,962,114 | | | - | | | - | | | - | | | - | | | - | | | 1,962,114 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Warrants issued for consulting expense in December 2003 | | | - | | | - | | | 29,761 | | | - | | | (29,761 | ) | | - | | | - | | | - | | | - | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Options issued for consulting services in August and November 2003 | | | - | | | - | | | 181,010 | | | - | | | (181,010 | ) | | - | | | - | | | - | | | - | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Amortization of deferred consulting expenses | | | - | | | - | | | - | | | - | | | 1,427,336 | | | - | | | - | | | - | | | 1,427,336 | |
See accompanying notes to the condensed consolidated financial statements.
DDS TECHNOLOGIES USA, INC.
(FORMERLY FISHTHEWORLD HOLDINGS, INC.)
AND SUBSIDIARY
(A DEVELOPMENT STAGE COMPANY)
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
FOR THE PERIOD FROM JULY 17, 2002 (INCEPTION) THROUGH JUNE 30, 2004
(UNAUDITED)
| | Common Stock | | Additional Paid-In Capital | | | | Deferred Consulting Expense | | Note Receivable Related Party | | Interest Receivable Related Party | | Accumulated Deficit | | Total | |
| | Shares | | Amount | | | | | | | | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
Common stock issued for services in February 2004 at $5.88 per share | | | 20,000 | | | 2 | | | 117,498 | | | - | | | (117,500 | ) | | - | | - | - | - |
| | | | | | | | | | | | | | | | | | | | | | |
Warrants issued for consulting expense in February 2004 | | | - | | | - | | | 42,454 | | | - | | | (42,454 | ) | | - | | - | - | - |
| | | | | | | | | | | | | | | | | | | | | | |
Warrants issued for consulting expense in April 2004 | | | - | | | - | | | 170,052 | | | - | | | (170,052 | ) | | - | | - | | - | | | - | |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock issued for services in May 2004 at $2.55 per share | | | 10,000 | | | 1 | | | 25,499 | | | - | | | (25,500 | ) | | - | | - | | - | | | - | |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Warrants issued for consulting expense in May 2004 | | | - | | | - | | | 12,165 | | | - | | | (12,165 | ) | | - | | - | | - | | | - | |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock issued for cash in May 2004 at $3.30 per share, net | | | 490,439 | | | 49 | | | 741,680 | | | - | | | - | | | - | | - | | - | | | 741,680 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Warrants issued with the sale of common stock in May 2004 | | | - | | | - | | | 714,876 | | | - | | | - | | | - | | - | | - | | | 714,876 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Amortization of deferred consulting expenses | | | - | | | - | | | - | | | | | | 1,312,349 | | | - | | - | | - | | | 1,312,349 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest receivable related party | | | - | | | - | | | - | | | - | | | - | | | - | | (1,844 | ) | - | | | (1,844 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Net loss: | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
July 17, 2002 (inception) through December 31, 2002 | | | - | | | - | | | - | | | - | | | - | | | - | | - | | (407,803 | ) | | (407,803 | ) |
Year ended December 31, 2003 | | | - | | | - | | | - | | | - | | | - | | | - | | - | | (4,670,321 | ) | | (4,670,321 | ) |
Six Months ended June 30, 2004 | | | - | | | - | | | - | | | - | | | - | | | - | | - | | (2,698,570 | ) | | (2,698,570 | ) |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
BALANCE, JUNE 30, 2004 | | | 19,235,542 | | | 1,923 | | | 18,171,587 | | | - | | | (411,855 | ) | | (235,000 | ) | (4,918 | ) | (7,776,694 | ) | | (9,745,043 | ) |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
See accompanying notes to the condensed consolidated financial statements.
DDS TECHNOLOGIES USA, INC.
(FORMERLY FISHTHEWORLD HOLDINGS, INC.)
AND SUBISIDIARY
(A DEVELOPMENT STAGE COMPANY)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
| | | For the Six Months Ended June 30, 2004 | | | For the Six Months Ended June 2003 | | | For the Period From July 17, 2002 (Inception) Through June 30, 2004 | |
| |
| |
| |
| |
CASH FLOWS FROM OPERATING ACTIVITIES: | | | | | | | | | | |
Net loss | | $ | (2,698,570 | ) | $ | (1,665,813 | ) | $ | (7,776,694 | ) |
Adjustments to reconcile net loss to net cash used in operating activities: | | | | | | | | | | |
Depreciation expense | | | 2,829 | | | 1,427 | | | 6,845 | |
Amortization of deferred consulting expense | | | 1,312,349 | | | 212,475 | | | 2,739,685 | |
Common stock issued for services | | | - | | | - | | | 465,000 | |
Other non-cash expenses | | | - | | | 4,112 | | | - | |
Changes in operating assets and liabilities: | | | | | | | | | | |
Prepaid expenses and other assets | | | 165,185 | | | (1,847 | ) | | (161,663 | ) |
Accrued expenses | | | (143,269 | ) | | 675,932 | | | 406,610 | |
| | |
| |
| |
| |
Net Cash Used In Operating Activities | | | (1,361,476 | ) | | (733,714 | ) | | (4,320,217 | ) |
| |
| |
| |
| |
CASH FLOWS FROM INVESTING ACTIVITIES: | | | | | | | | | | |
Deposit on purchase of machinery | | | - | | | - | | | (4,000,976 | ) |
Purchases of fixed assets | | | (31,496 | ) | | (150 | ) | | (59,789 | ) |
Acquisition of license | | | - | | | (200,000 | ) | | (700,000 | ) |
Note receivable and accrued interest –related party | | | (1,846 | ) | | (235,000 | ) | | (239,920 | ) |
| |
| |
| |
| |
Net Cash Used In Investing Activities | | | (33,342 | ) | | (435,150 | ) | | (5,000,685 | ) |
| |
| |
| |
| |
CASH FLOWS FROM FINANCING ACTIVITIES: | | | | | | | | | | |
Sales of common stock | | | 1,456,607 | | | 1,100,000 | | | 10,556,972 | |
| |
| |
| |
| |
Net Cash Provided By Financing Activities | | | 1,456,607 | | | 1,100,000 | | | 10,556,972 | |
| |
| |
| |
| |
NET INCREASE (DECREASE) IN CASH | | | 61,789 | | | (108,864 | ) | | 1,236,070 | |
| | | | | | | | | | |
CASH – BEGINNING OF PERIOD | | | 1,174,281 | | | 125,105 | | | - | |
| |
| |
| |
| |
CASH - END OF PERIOD | | $ | 1,236,070 | | $ | 16,241 | | $ | 1,236,070 | |
| |
| |
| |
| |
Deposits on purchase of machinery applied to fixed asset purchases | | $ | 801,791 | | $ | - | | $ | 801,791 | |
| |
| |
| |
| |
Common stock issued for license valued at $1.00 per share | | $ | - | | $ | 500,000 | | $ | 4,000,000 | |
| |
| |
| |
| |
Warrants issued for deferred consulting services | | $ | 224,671 | | $ | - | | $ | 1,509,519 | |
| |
| |
| |
| |
Common stock issued for deferred consulting expenses | | $ | 143,000 | | $ | - | | $ | 1,451,250 | |
| |
| |
| |
| |
Options issued for deferred consulting services | | $ | - | | $ | - | | $ | 99,636 | |
| |
| |
| |
| |
Common stock issued to consultant to settle contract dispute | | $ | - | | $ | - | | $ | 60,000 | |
| |
| |
| |
| |
See accompanying notes to the condensed consolidated financial statements.
DDS TECHNOLOGIES USA, INC.
(FORMERLY FISHTHEWORLD HOLDINGS, INC.)
AND SUBISIDIARY
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
AS OF JUNE 30, 2004
(UNAUDITED)
NOTE 1 BACKGROUND AND BASIS OF PRESENTATION
DDS Technologies USA, Inc. (formerly Fishtheworld Holdings, Inc.) and subsidiary (the "Company") is a development stage company with no revenues since its inception on July 17, 2002. The Company has been engaged in the process of obtaining the license rights and exclusive marketing rights for North America, Central America, the Caribbean (excluding Cuba), South America and Africa for a dry disaggregation system, which is a system that converts certain waste into value added products for further processing or resale.
Since its inception, the Company has been dependent upon the receipt of capital investment to fund its continuing activities. In addition to the normal risks associated with a new business venture, the Company's product development may not be successfully completed or it may not be a commercial success. The Company's ability to execute its business plan will depend on its ability to obtain additional financing and achieve a profitable level of operations. The Company may not be able to obtain sufficient financing. The Company may not generate substantial revenues and its business operations may not be profitable.
On November 14, 2002, Black Diamond Industries, Inc., ("Black Diamond") a public Florida corporation conducting no business other than to seek a suitable acquisition partner, acquired all of the outstanding shares of common stock of DDS Holdings, Inc., a Nevada company, pursuant to a securities exchange agreement dated October 27, 2002. Under the terms of the securities exchange agreement, the stockholders of DDS Holdings, Inc. agreed to transfer all of the issued and outstanding shares of common stock of DDS Holdings, Inc. in exchange for an aggregate of 12,915,525 shares of common stock, or approximately 93%, of Black Diamond. Immediately prior to, and in conjunction with the transaction, the sole director and officer and majority shareholder of Black Diamond returned 13,564,350 shares of common stock to treasury.
In December 2002, Black Diamond changed its name to DDS Technologies USA, Inc. and reincorporated in the State of Delaware.
Under a share exchange agreement entered into on April 4, 2003, Fishtheworld Holdings, Inc. ("Fishtheworld") a public Florida corporation conducting no business other than to seek a suitable acquisition partner, acquired 88.5% of DDS Technologies USA, Inc. in exchange for 15,367,255 shares of common stock, or approximately 97% of the then issued and outstanding shares, of Fishtheworld. DDS Technologies USA, Inc. also paid a cash consideration of $200,000 to the shareholders of Fishtheworld, which has been accounted for as merger costs in the December 31, 2003 statement of operations. Immediately prior to the share exchange, the majority shareholder of Fishtheworld returned 8,571,000 shares to treasury and resigned as the sole director and officer of Fishtheworld. The members of the Board of Directors of the Company became members of the Board of Directors of Fishtheworld. DDS Technologies USA, Inc. adopted the December 31st year-end of Fishtheworld. In May 2003, Fishtheworld changed its name to DDS Technologies, USA, Inc. and reincorporated in the state of Nevada. As a result of the reincorporation, the Company’s par value for its preferred and common stock changed to $.0001 per share.
DDS TECHNOLOGIES USA, INC.
(FORMERLY FISHTHEWORLD HOLDINGS, INC.)
AND SUBISIDIARY
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
AS OF JUNE 30, 2004
(UNAUDITED)
Generally accepted accounting principles in the United States of America require that a company whose stockholders retain a majority interest in a business combination be treated as the acquirer for accounting purposes. Since Black Diamond and Fishtheworld were public shells and DDS Holdings, Inc. is a development stage company with no revenues, the transactions were treated as recapitalizations of the Company.
NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION
(A) Principles of Consolidation
The accompanying condensed consolidated financial statements include the accounts of DDS Technologies USA, Inc. and its wholly owned subsidiary. All material intercompany accounts and transactions have been eliminated.
(B) License
The license is recorded at its acquisition cost. Under the terms of the agreement, the license has a 20-year life, which expires in May 2022, and will be amortized over the expiration term when the Company commences operations which generate revenues.
(C) Use of Estimates
The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
DDS TECHNOLOGIES USA, INC.
(FORMERLY FISHTHEWORLD HOLDINGS, INC.)
AND SUBISIDIARY
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
AS OF JUNE 30, 2004
(UNAUDITED)
Net loss per common share (basic and diluted) is based on the net loss divided by the weighted average number of common shares outstanding during each period. Common stock equivalents were not included in the calculation of diluted loss per share as their effect would be anti-dilutive.
(E)Concentrations
The Company maintains the majority of its cash balances in a financial institution located in Boca Raton, Florida. The balance in the institution is insured by the Federal Deposit Insurance Corporation up to $100,000. At June 30, 2004, the Company’s uninsured cash amounted to $1,141,989.
(F) Interim Consolidated Financial Statements
The condensed consolidated financial statements as of June 30, 2004 and for the three and six months ended June 30, 2004 and 2003, and for the period from July 17, 2002 (inception) through June 30, 2004, are unaudited. In the opinion of management, such condensed consolidated financial statements include all adjustments (consisting of normal recurring accruals) necessary for the fair presentation of the consolidated financial position and the consolidated results of operations. The consolidated results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year. The condensed consolidated balance sheet information as of December 31, 2003 was derived from the audited consolidated financial statements included in the Company’s Annual Report Form 10-KSB. The interim condensed consolidated financial statements should be read in conjunction with that report.
(G) Recent Accounting Pronouncements
In March 2004, the U.S. Securities and Exchange Commission’s Office of the Chief Accountant and the Division of Corporate Finance released Staff Accounting Bulletin (“SAB”) No. 105, “Loan Commitments Accounted for as Derivative Instruments”. This bulletin contains specific guidance on the inputs to a valuation-recognition model to measure loan commitments accounted for at fair value, and requires that fair-value measurement include only differences between the guaranteed interest rate in the loan commitment and market interest rate, excluding any expected future cash flows related to the customer relationship or loan servicing. In addition, SAB No. 105 requires the disclosure of the accounting policy for loan commitments, including methods and assumptions used to estimate
DDS TECHNOLOGIES USA, INC.
(FORMERLY FISHTHEWORLD HOLDINGS, INC.)
AND SUBISIDIARY
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
AS OF JUNE 30, 2004
(UNAUDITED)
the fair value of loan commitments, and any associated hedging strategies. SAB No. 105 is effective for derivative instruments entered into subsequent to March 31, 2004 and should also be applied to existing instruments as appropriate.
The Company does not anticipate that this pronouncement will have a material impact on the consolidated financial statements.
NOTE 3 RELATED PARTY TRANSACTIONS
For the three months ended June 30, 2004 and 2003, and for the period from July 17, 2002 (inception) through June 30, 2004, the Company incurred consulting expenses of $105,000, $116,800 and $836,500, respectively, from stockholders of the Company.
For the six months ended June 30, 2004 and 2003, the Company incurred consulting expenses of $232,500 and $246,000, respectively.
In connection with the consulting services aforementioned, in April 2004, the Company entered into a consulting agreement with a stockholder and former president of the Company. Pursuant to the terms of this agreement, the Company pays the consultant a monthly fee of $15,000 for a period of three years.
In connection with the consulting services aforementioned, in March 2004, the Company entered into a consulting agreement with one of its stockholders whereby the Company pays the consultant a monthly fee of $15,000 for a term of seven years.
NOTE 4 MACHINERY
In May 2004, the Company installed its first commercial dry disaggregation machine in a production plant of an Iowa ethanol producer with which the Company entered into a pre-formation agreement in August 2003. The Company and the Iowa ethanol producer are performing lab testing and are determining when the machine will be ready for commercial use. In connection with the installation, the Company reclassified $801,791 from deposit on purchase of machinery to fixed assets, in addition to capitalizing $31,496 of shipping costs. Also, see Note 9(C).
NOTE 5 STOCK OPTIONS
The Company has established a Stock Option Plan (the "Plan") to attract, retain and motivate key employees, to provide an incentive for them to achieve long-range performance goals and to enable them to participate in the long-term growth of the Company. Options granted under
DDS TECHNOLOGIES USA, INC.
(FORMERLY FISHTHEWORLD HOLDINGS, INC.)
AND SUBISIDIARY
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
AS OF JUNE 30, 2004
(UNAUDITED)
the Plan may include non-qualified stock options as well as incentive stock option intended to qualify under Section 422A of the Internal Revenue Code. The aggregate number of shares that may be issued under the Plan or exercise of options must not exceed 3,000,000 shares. Each stock option agreement specifies when all or any installment of the option becomes exercisable.
In May and October 2003, the Company granted stock options to two executive employees. The Company applies Accounting Principles Board ("APB") Opinion 25, Accounting for Stock Issued to Employees, and related interpretations in accounting for option granted to employees. Under APB Opinion 25, if the exercise price of stock option equals or exceeds the market price of the underlying stock on the date of grant, no compensation cost is recognized. For the options granted in May 2003, the exercise price of each option equaled the market price of the Company's stock on the date of grant. The options expire 10 years from the date of grant. Pursuant to the option agreement, options to purchase 100,000 shares vested immediately and options to purchase 50,000 shares vested monthly though March 15, 2004. For the option granted in October 2003, the exercise price of each option equaled the market price of the Company's stock on the date of grant and the options vest three years from the date of grant.
In October 2003, the Company also granted stock options to the members of its Board of Directors as compensation for their services on the board. Each director was issued a stock option to purchase 50,000 shares of common stock at an exercise price of $8.00 per share.
SFAS No. 123, Accounting for Stock-Based Compensation, as amended by SFAS No. 148, Accounting for Stock-Based Compensation – Transition and Disclosure, requires the Company to provide pro forma information regarding net income and earnings per share for each period presented as if compensation cost for the Company's stock options had been determined in accordance with the fair value based method prescribed in SFAS No. 123. The Company estimates the fair value of each stock option at the grant date by using the Black-Scholes option pricing model with the following weighted average assumptions used for the grants in May 2003; no dividend yield for all years; expected volatility of 74%; risk-free interest rate of 3%, and an expected life of 10 years.
DDS TECHNOLOGIES USA, INC.
(FORMERLY FISHTHEWORLD HOLDINGS, INC.)
AND SUBISIDIARY
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
AS OF JUNE 30, 2004
(UNAUDITED)
Under the accounting provisions of SFAS No. 123, as amended by SFAS No. 148, the Company's net loss and net loss per common share would have been as follows:
| | | For the Six Months Ended June 30, 2004 |
| | |
|
Net loss | As Reported | $ | (2,698,570) |
| Pro Forma | $ | (3,067,207) |
Net loss per common | As Reported | $ | (0.14) |
share - basic and diluted | Pro Forma | $ | (0.16) |
A summary of the status of the Company’s option plans as of June 30, 2004 and the changes during the period ending on that date is presented below:
| | Shares | | | Weighted Average Exercise Price | |
| |
| |
| |
Outstanding at December 31, 2003 | | | 1,350,000 | | $ | 6.37 | |
Granted | | | - | | $ | - | |
Forfeited | | | - | | $ | - | |
Outstanding at June 30, 2004 | | | 1,350,000 | | $ | 6.37 | |
| |
| |
| |
Options exercisable at June 30, 2004 | | | 600,000 | | | | |
| |
| | | | |
Weighted average fair value of options granted to employees during the period from July 17, 2002 (inception) through June 30, 2004 | | $ | 3.20 | | | | |
| |
| | | | |
The following table summarizes information about the stock options outstanding at June 30, 2004:
Options Outstanding | | Options Exercisable |
| |
|
| Exercise Price | | Number Outstanding at June 30, 2004 | | Weighted Average Remaining Contractual Life | | Weighted Average Exercise Price | | Number Exercisable at June 30, 2004 | | Weighted Average Exercise Price |
|
| |
| |
| |
| |
| |
|
$ | 5.00 | | 600,000 | | 8.88 | $ | 5.00 | | 600,000 | $ | 5.00 |
$ | 7.00 | | 400,000 | | 3.43 | $ | 7.00 | | - | $ | 7.00 |
$ | 8.00 | | 350,000 | | 9.43 | $ | 8.00 | | - | $ | 8.00 |
NOTE 6 SALES OF COMMON STOCK
In May 2004, the Company entered into stock purchase agreements with several accredited investors for the sale of common stock. The Company sold 490,439 shares for proceeds of $1,618,450 ($1,456,556 net of commissions). The agreements provide for the purchase of shares at $3.30 per share plus warrants for an equal number of shares purchased. The warrants are exercisable at any time for a period of three years at a strike price of $3.75 per share. The 490,439 warrants were valued using the Black-Scholes pricing model and resulted in a fair value of $714,876. The net proceeds of $1,456,556 were allocated between the fair value of the warrants issued with the common stock ($714,876) and the common stock ($741,680).
|
| 12 | |
|
DDS TECHNOLOGIES USA, INC. (FORMERLY FISHTHEWORLD HOLDINGS, INC.) AND SUBISIDIARY (A DEVELOPMENT STAGE COMPANY) NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2004 (UNAUDITED) |
NOTE 7 INVESTMENT BANKING AGREEMENT
On April 23, 2003, the Company entered into a one-year agreement with a consulting company for investment banking and other related services. Pursuant to this agreement, the Company issued the consulting company a warrant to acquire 500,000 shares of the Company’s common stock at an exercise price of $6.50 per share. The warrant is exercisable for a period of five years. The warrant was valued using the Black-Scholes pricing model and resulted in a fair value of $1,274,848. The amount was being amortized over the life of the consulting agreement resulting in consulting expense of $106,237 and $424,949 for the three and six months ended June 30, 2004, respectively, and $1,274,848 for the period from July 17, 2002 (inception) through June 30, 2004.
NOTE 8 CONSULTING AND MARKETING AGEEMENTS
On August 14, 2003, the Company entered into an agreement with a marketing company for business advisory and various other investment and marketing services. The agreement is for a term of one year. For these services, the Company pays the marketing company $5,000 per month. In addition, the Company is required to issue the marketing company 10,000 shares of restricted common stock per quarter. The first 10,000 shares were issued upon signing the agreement and 10,000 shares were issued in each of December 2003, February 2004 and May 2004. Based on the closing market price of the Company’s common stock on the contractual dates of the agreement, $55,750 and $77,250 were expensed to consulting fees for the three and six months ended June 30, 2004, respectively, and $182,250 for the period from July 17, 2002 (inception) through June 30, 2004. The remaining unamortized balance of $12,750 is presented in the condensed consolidated balance sheet as deferred consulting expenses. The Company further agreed to issue 35,000 stock options per quarter with a strike price of $8.00 per share, expiring three years from the date of grant. During 2003, the Company issued all 105,000 stock options due under the agreement. The Company estimated the fair value of the stock options at the grant dates by using the Black-Scholes option-pricing model with the following weighted average assumptions: no dividend yield for all years; expected volatility of 83%; risk-free interest rate of 3% and an expected life of three years. This resulted in a fair value of $235,629. The amount is being amortized over the life of the agreement resulting in consulting expense of $48,537 and $106,724 for the three and six months ended in June 30, 2004, respectively, and $229,547 the period from July 17, 2002 (inception) through June 30, 2004 and has deferred $6,082 of expenses.
|
| 13 | |
|
DDS TECHNOLOGIES USA, INC. (FORMERLY FISHTHEWORLD HOLDINGS, INC.) AND SUBISIDIARY (A DEVELOPMENT STAGE COMPANY) NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2004 (UNAUDITED) |
On September 12, 2003, the Company entered into a one-year agreement with a financial consulting firm. The consulting firm provides analytical review of the Company's financial information and assists the Company as its financial advisor and investment banker. As compensation for these services, in 2003 the Company issued 100,000 restricted shares of common stock to the financial consulting firm. The Company recognized $193,500 and $387,000 in consulting fee expense for the three and six months ended June 30, 2004, respectively, and $612,750 for the period from July 17, 2002 (inception) through June 30, 2004 and has deferred $161,250 of expenses.
On September 19, 2003, the Company entered into a one-year agreement with an individual. The individual provides a list of names of potential investors and other services to the Company. As compensation for these services, in 2003 the Company issued 50,000 shares of restricted common stock. The Company recognized $98,750 and $197,500 in consulting fee expense for the three and six months ended June 30, 2004, respectively, and $312,709 for the period from July 17, 2002 (inception) through June 30, 2004 and has deferred $82,291 of expenses.
On December 8, 2003, the Company entered into an eight-month agreement with a marketing company. The marketing company provides business advisory and various other investment and marketing services to the Company. For these services, the Company pays the marketing company $5,000 per month. In addition, the Company issued the marketing company warrants for the purchase of 10,000 shares of common stock at an exercise price of $9.00 per share. The warrants expire on December 7, 2005. The warrants were valued using the Black-Scholes pricing model and resulted in a fair value of $29,761. The amount is amortized over the life of the agreement resulting in consulting expense of $11,160 and $22,320 for the three and six months ended June 30, 2004, respectively, and $26,040 for the period from July 17, 2002 (inception) through June 30, 2004. The remaining unamortized balance of $3,721 is presented in the condensed consolidated balance sheet as deferred consulting expense. The Company terminated this marketing agreement in February 2004.
On April 26, 2004, the Company entered into a 14-month agreement with a marketing company. The marketing company provides business advisory and various other investment and marketing services to the Company. The Company paid the marketing company $25,000 upon signing the agreement and pays a monthly fee of $5,000. In addition, the Company issued warrants for the purchase of 400,000 shares of common stock at exercise prices of $3.75 and $4.25 per share. The warrants are exercisable until April 26, 2007. The warrants were valued using the Black-Scholes pricing model and resulted in a fair value of $170,052. The amount is amortized over the life of the agreement resulting in consulting expense of $24,294 for the six months ended June 30, 2004. The remaining unamortized balance of $145,758 is presented in the condensed consolidated balance sheet as deferred consulting expense.
|
| 14 | |
|
DDS TECHNOLOGIES USA, INC. (FORMERLY FISHTHEWORLD HOLDINGS, INC.) AND SUBISIDIARY (A DEVELOPMENT STAGE COMPANY) NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2004 (UNAUDITED) |
NOTE 9 COMMITMENT AND CONTINGENCIES
(A) Contingencies
The Company granted registration rights to certain investors in its July 2, 2003 private placement of securities. Under those rights, if the Company did not file a registration statement within 45 days of closing, the Company owes the investors an aggregate of approximately $13,000 per month in penalties. The Company began incurring those penalties on August 16, 2003. The registration statement was filed on November 12, 2003. The Company has accrued $37,611 of penalties which are included in accrued expenses at June 30, 2004.
(B) Litigation
The Company is a defendant in a lawsuit whereby the plaintiff contends that it is entitled to a commission for allegedly procuring financing for a transaction. The Company filed a Motion to Dismiss the plaintiff's complaint, which has not yet been set for hearing. The plaintiff seeks damages totaling $175,584 plus interest from December 31, 2002. The Company believes the suit is without merit and is vigorously defending its position. In the opinion of management, this suit will not have a material effect on the Company's condensed consolidated financial position or results of operations.
The Company received a potential claim from two shareholders alleging that the Company failed to register their shares for re-sale in the Company’s last registration statement, filed on Form S-1 under the Securities Act of 1933, as amended on November 12, 2003 and an amendment thereto on December 13, 2003. In addition, these shareholders have alleged that they were induced erroneously into surrendering shares of DDS Holdings, Inc. in connection with the reorganization into Black Diamond Industries, Inc. Although the Company believes that it has defenses to these alleged actions, the Company is attempting to reach an amicable settlement for these claims. There can be no assurance that these disputes will be favorably resolved, if at all, or that these claims will not have a material adverse effect on the Company. The Company does not believe a provision is necessary at June 30, 2004 for this matter.
|
| 15 | |
|
DDS TECHNOLOGIES USA, INC. (FORMERLY FISHTHEWORLD HOLDINGS, INC.) AND SUBISIDIARY (A DEVELOPMENT STAGE COMPANY) NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2004 (UNAUDITED) |
(C) Other Agreements
On August 1, 2003, the Company entered into a Pre-Formation agreement with an Iowa ethanol producer. Under the terms of this agreement, the Company and the Iowa entity will form a limited liability company which will use the DDS technology to convert corn stover and other waste materials into intermediate products for further processing into ethanol for resale. Under the agreement, each plant will be owned by a limited liability company which will be separately capitalized with an intended 50% ownership interest for each of the Company and the Iowa ethanol producer. The dry disaggregation machine will be leased to the limited liability company for a flat fee plus a royalty to be determined with the Company receiving a greater royalty on products made from non-fermentable sugars that can only be processed using the Company’s technologies. The Company installed one of its dry disaggregation technology units in the ethanol producer’s facility in Iowa (See Note 4).
On September 12, 2003, the Company entered into a one-year letter of intent with a Florida Cooperative of citrus growers. Under the terms of this letter, the cooperative will lease space in its facility without charge and the Company will install one of its dry disaggregation technology units for the processing of citrus pomace into feed by-products.
On January 9, 2004, the Company entered into a Memorandum of Understanding (“MOU”) with a large Columbian sugar producer. Under the terms of the MOU, a joint venture pilot program will be developed in which the Company will provide and install one of its dry disaggregation technology units for the production of ethanol in the sugar producer’s facility in Columbia.
NOTE 10 SUBSEQUENT EVENTS
On July 31, 2004, the Company entered into a Memorandum of Understanding with Giancarlo Lo Fiego and Adriano Zapparoli. In it, Messrs. Lo Fiego and Zapparoli agreed to cause High Speed Fragmentation B.V. (“HSF”), Intel Trust S.A., a Switzerland trust, Haras Engineering Corp. a Panama entity ("HEC"), to execute the Memorandum of Understanding. Pursuant to the terms of the Memorandum of Understanding, the Company, whose original license to the dry disaggregation technology and the underlying patent was previously restricted to North, South and Central America, the Caribbean (excluding Cuba) and Africa, has acquired rights to sell, and distribute the technology and the underlying patent throughout the world. The Company has terminated its
|
| 16 | |
|
DDS TECHNOLOGIES USA, INC. (FORMERLY FISHTHEWORLD HOLDINGS, INC.) AND SUBISIDIARY (A DEVELOPMENT STAGE COMPANY) NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2004 (UNAUDITED) |
obligation to pay royalties under the license agreement that was originally with DDS Technologies Ltd., a United Kingdom company (“DDS UK”), and was subsequently assigned to HSF. The Company agreed to release 390,000 Euros currently on deposit with Intel Trust and forgo claims to another 1,000,000 Euros previously paid by the Company. HSF will remit to the Company 610,000 Euros previously deposited by the Company. The Company and an entity to be designated by HSF will enter into a license agreement pursuant to which the entity will receive a license from the Company that will permit the entity to sell, license, rent, and distribute products embodying the technology throughout Europe, Asia and Oceania, on the following terms:
| • | The Company and the entity will each use reasonable commercial efforts to ascertain commercially viable new products that may be manufactured or derived through the use of the technology. |
| | |
| • | The party that discovers such a product shall have the exclusive right, for a period ninety days, to market the product and, enter into a bona fide binding agreement for the sale of the product in Europe, Asia and Oceania. Thereafter, either party may market the product in Europe, Asia and Oceania. |
| | |
| • | The Company shall have the exclusive right to market such product outside of Europe, Asia and Oceania and after the lapse of the ninety day period when the entity is the party discovering the product, non-exclusive rights to market the product in Europe, Asia and Oceania. |
| | |
| • | Each shall pay to the other royalties equal to five percent of the gross revenues from the sale or lease of such products in Europe, Asia and/or Oceania. |
| | |
| • | The Company expects to invest or advance funds to the entity in the future. |
The transactions described above arose in connection with a complaint the Company filed on July 26, 2004 against Umberto Manola, DDS UK, Intel Trust, HEC, HSF, Erich Stanchich and Giancarlo Lo Fiego in the United States District Court for the Southern District of Florida, Miami Division. The claims set forth in the complaint arose from correspondence, purportedly submitted on behalf of the former licensor, DDS UK, or its shareholders, setting forth allegations that the patent covering the technology was never effectively transferred to the present licensor, HSF, and that DDS UK remained the owner of the 4,000,000 shares issued by the Company and purportedly assigned by DDS UK to HSF in connection with various agreements that have been previously disclosed. HSF denied such allegations, claiming that all rights and obligations under the original license were effectively transferred to HSF. The Company filed the complaint to seek a declaratory judgment as to its rights and the actual ownership of the shares the Company originally issued in payment for the license. The Company intends to engage in settlement negotiations with all parties to the lawsuit and is confident that irrespective of the outcome of the litigation, the Company’s position as the licensee of the technology will be at least as favorable as it was prior to entering into the Memorandum of Understanding. If settlement negotiations are not productive, the Company intends to pursue the litigation and any other litigation necessary to determine its rights and seek damages.